BioCentury
ARTICLE | Clinical News

Aflunov regulatory update

April 25, 2011 7:00 AM UTC

In November, the European Commission approved Aflunov vaccine from Novartis to prevent influenza A (H5N1) virus infection in adults. In 2008, Novartis withdrew an MAA for the adjuvanted pre- pandemic ...